We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$12.6B
AUM Growth
+$1.67B
Cap. Flow
+$1.36B
Cap. Flow %
10.84%
Top 10 Hldgs %
18.39%
Holding
1,089
New
136
Increased
462
Reduced
284
Closed
55

Sector Composition

Rank Sector Weight
1 Financials 17.33%
2 Healthcare 17.13%
3 Technology 15.26%
4 Communication Services 11%
5 Consumer Discretionary 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KN icon
926
Knowles
KN
$3.36B
$212K ﹤0.01%
12,400
IPXL
927
DELISTED
Impax Laboratories, Inc.
IPXL
$212K ﹤0.01%
13,100
GBT
928
DELISTED
Global Blood Therapeutics, Inc.
GBT
$211K ﹤0.01%
+7,400
New +$220K
FULT icon
929
Fulton Financial
FULT
$4.67B
$206K ﹤0.01%
10,758
-9,600
-47% -$175K
CXT icon
930
Crane NXT
CXT
$3.13B
$204K ﹤0.01%
+7,485
New +$202K
HTHT icon
931
Huazhu Hotels Group
HTHT
$13.2B
$201K ﹤0.01%
10,000
VSH icon
932
Vishay Intertechnology
VSH
$5.03B
$201K ﹤0.01%
+12,100
New +$199K
DVAX
933
DELISTED
Dynavax Technologies
DVAX
$200K ﹤0.01%
20,000
MZTI
934
The Marzetti Company
MZTI
$3.02B
$191K ﹤0.01%
1,576
POT
935
DELISTED
Potash Corp Of Saskatchewan
POT
$190K ﹤0.01%
11,704
-800
-6% -$13.2K
VNDA icon
936
Vanda Pharmaceuticals
VNDA
$308M
$184K ﹤0.01%
11,100
PACB icon
937
Pacific Biosciences
PACB
$363M
$179K ﹤0.01%
48,000
VRN
938
DELISTED
Veren
VRN
$171K ﹤0.01%
22,244
+3,600
+19% +$33.6K
LSTR icon
939
Landstar System
LSTR
$6.01B
$169K ﹤0.01%
1,978
GEF icon
940
Greif
GEF
$5.07B
$168K ﹤0.01%
3,046
+198
+7% +$11.2K
ENTA icon
941
Enanta Pharmaceuticals
ENTA
$388M
$167K ﹤0.01%
4,600
TKC icon
942
Turkcell
TKC
$4.76B
$167K ﹤0.01%
20,487
-3,100
-13% -$25.8K
BKH icon
943
Black Hills Corp
BKH
$5.54B
$149K ﹤0.01%
2,200
VMI icon
944
Valmont Industries
VMI
$9.5B
$148K ﹤0.01%
1,000
NMFC icon
945
New Mountain Finance
NMFC
$723M
$146K ﹤0.01%
10,000
NVAX icon
946
Novavax
NVAX
$1.27B
$144K ﹤0.01%
6,280
WWW icon
947
Wolverine World Wide
WWW
$1.56B
$141K ﹤0.01%
5,121
NRG icon
948
NRG Energy
NRG
$25.1B
$140K ﹤0.01%
8,200
ATRA icon
949
Atara Biotherapeutics
ATRA
$74.3M
$134K ﹤0.01%
368
JBLU icon
950
JetBlue
JBLU
$2.34B
$134K ﹤0.01%
5,852

Similar funds

DekaBank Deutsche Girozentrale's Q2 2017 Portfolio in Review

As of Q2 2017, DekaBank Deutsche Girozentrale held 1,089 positions worth $12.6B, up 15% from $10.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

DekaBank Deutsche Girozentrale deployed $1.36B of net new capital in Q2 2017, opening 136 new positions and adding to 462 existing holdings. Its largest new stake was Alphabet (Google) Class A: 4,732,820 shares worth $223M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was IBM, an estimated $24.7M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q2 2017 buy was Alphabet (Google) Class A: 4,732,820 shares worth $223M.
  • DekaBank Deutsche Girozentrale added most to Deutsche Bank in Q2 2017, an estimated $122M increase.
  • DekaBank Deutsche Girozentrale's biggest Q2 2017 reduction was IBM, cutting an estimated $24.7M.
  • DekaBank Deutsche Girozentrale fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $27.1M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 18% of its $12.6B portfolio in Q2 2017.
  • DekaBank Deutsche Girozentrale opened 136 new positions and closed 55 in Q2 2017.
  • DekaBank Deutsche Girozentrale's portfolio value rose 15% quarter-over-quarter to $12.6B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2017, filed 2 Aug 2017.